Jasper freeman

Jasper Freeman has extensive work experience in the pharmaceutical industry. Jasper currently works as the National Account Director-West at scPharmaceuticals, where they are responsible for managing relationships with various insurers. Jasper is involved in the launch of a new FDA approved product called Furoscix, which aims to improve outcomes for patients with worsening heart failure. Prior to this role, Jasper was the Territory Account Director at Sarfez Pharmaceutical Inc.

Before that, Jasper worked as a Market Access Consultant at 1798/Freeman Bio Consulting, LLC for five years. In this role, they provided consulting services related to market access strategies. Jasper also served as the Director of Payer & PBM Accounts-West at Celgene, where they managed a team covering the western U.S. Jasper has held director-level positions at Vertex Pharmaceuticals and Amgen, where they oversaw specialty pharmacy operations.

Earlier in their career, Jasper held director-level positions at Bayer Pharmaceuticals and Bristol-Myers Squibb, focusing on managed markets and managed care, respectively. Overall, Jasper Freeman's work experience demonstrates a strong background in market access, payer relations, and specialty pharmacy management.

Jasper Freeman holds a Bachelor of Science (B.S.) degree in Chemistry Physics from the University of Wisconsin-River Falls. The specific start and end years of their education are not provided.